Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
Sell
37
UHT Quote, Financials, Valuation and Earnings
Last price:
$38.23
Seasonality move
:
-0.02%
Day range:
$37.75 - $38.42
52-week range:
$32.27 - $47.30
Dividend yield:
7.68%
P/E ratio:
27.46x
P/S ratio:
5.34x
P/B ratio:
2.94x
Volume:
42.9K
Avg. volume:
69K
1-year change:
11.61%
Market cap:
$528.7M
Revenue:
$99M
EPS (TTM):
$1.39
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Universal Health Realty Income Trust has -- downside to fair value with a price target of -- per share.
UHT vs. S&P 500
-
Over the past 5 trading days, Universal Health Realty Income Trust has overperformed the S&P 500 by 1.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Universal Health Realty Income Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Health Realty Income Trust has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Universal Health Realty Income Trust reported revenues of $24.6M.
Earnings Growth
-
Universal Health Realty Income Trust has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Universal Health Realty Income Trust reported earnings per share of $0.34.
Enterprise value:
889.8M
EV / Invested capital:
--
Price / LTM sales:
5.34x
EV / EBIT:
20.66x
EV / Revenue:
8.99x
PEG ratio (5yr expected):
1.09x
EV / Free cash flow:
18.97x
Price / Operating cash flow:
11.26x
Enterprise value / EBITDA:
12.62x
Gross Profit (TTM):
$93.5M
Return On Assets:
3.27%
Net Income Margin (TTM):
19.43%
Return On Equity:
10.13%
Return On Invested Capital:
3.47%
Operating Margin:
37.57%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $90.6M | $95.6M | $99M | $24.3M | $24.6M | |
| Gross Profit | $85.5M | $90.3M | $93.5M | $23M | $23.3M | |
| Operating Income | $30.7M | $31.3M | $36.8M | $8.2M | $9.3M | |
| EBITDA | $58.4M | $65.2M | $70.5M | $16.8M | $17.1M | |
| Diluted EPS | $1.53 | $1.11 | $1.39 | $0.26 | $0.34 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $16.4M | $116.7M | $105.1M | $105.8M | $105M | |
| Total Assets | $494M | $598.4M | $607.5M | $596.4M | $580.9M | |
| Current Liabilities | $256.4M | $284.4M | $311.3M | $340.6M | $360M | |
| Total Liabilities | $335M | $363.1M | $378.4M | $395.4M | $401.3M | |
| Total Equity | $159M | $235.3M | $229.1M | $200.9M | $179.5M | |
| Total Debt | $295.1M | $328.8M | $342.8M | $359.5M | $368.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $46.8M | $42.9M | $46.9M | $10.5M | $13.2M | |
| Cash From Investing | -$36.7M | -$19.1M | -$13.9M | $735K | -$2.7M | |
| Cash From Financing | -$25M | -$23.2M | -$34.2M | -$11.3M | -$9.7M | |
| Free Cash Flow | $46.8M | $42.9M | $46.9M | $18.1M | $13.2M | |
UHT
Sector
Market Cap
$528.7M
$973M
Price % of 52-Week High
80.7%
78.02%
Dividend Yield
7.68%
3.41%
Shareholder Yield
7.58%
3.41%
1-Year Price Total Return
11.61%
-2.58%
Beta (5-Year)
0.849
0.770
Dividend yield:
7.68%
Annualized payout:
$2.92
Payout ratio:
210.01%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$37.72
200-day SMA
Sell
Level
$40.85
Bollinger Bands (100)
Sell
Level
37.53 - 41.03
Chaikin Money Flow
Buy
Level
17.6M
20-day SMA
Sell
Level
$39.52
Relative Strength Index (RSI14)
Sell
Level
42.40
ADX Line
Sell
Level
27.87
Williams %R
Neutral
Level
-56.836
50-day SMA
Sell
Level
$39.78
MACD (12, 26)
Sell
Level
-0.74
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Sell
Level
-1.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6961)
Sell
CA Score
(Annual)
Level (-0.8817)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (2.5297)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
Stock Forecast FAQ
In the current month, UHT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UHT average analyst price target in the past 3 months is --.
-
Where Will Universal Health Realty Income Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Health Realty Income Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Universal Health Realty Income Trust?
Analysts are divided on their view about Universal Health Realty Income Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Health Realty Income Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is Universal Health Realty Income Trust's Price Target?
The price target for Universal Health Realty Income Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is UHT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Health Realty Income Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of UHT?
You can purchase shares of Universal Health Realty Income Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Health Realty Income Trust shares.
-
What Is The Universal Health Realty Income Trust Share Price Today?
Universal Health Realty Income Trust was last trading at $38.23 per share. This represents the most recent stock quote for Universal Health Realty Income Trust. Yesterday, Universal Health Realty Income Trust closed at $38.17 per share.
-
How To Buy Universal Health Realty Income Trust Stock Online?
In order to purchase Universal Health Realty Income Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will MSTY Go By 2030?
YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…
Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
75
SKGR alert for Apr 13
SK Growth Opportunities [SKGR] is down 0% over the past day.
Sell
45
DSDVY alert for Apr 16
DSV AS [DSDVY] is down 1.42% over the past day.
Buy
76
PDEX alert for Apr 16
Pro-Dex [PDEX] is down 4.05% over the past day.
